BioSpace News Archive

According to the latest market report published by Persistence Market Research, titled ‘Global Wireless Fetal Monitoring System: Industry Analysis (2013-2017) and Forecast (2018-2026)’, the global wireless fetal monitoring system is expected to expand at a CAGR of 6.8% during the forecast period 2018–2026. The wireless fetal monitoring systems is segmented based on product type, application, end user and region.

Today, the Association of Black Cardiologists (ABC) issued frequently asked questions (FAQ Watch) for healthcare providers related to COVID-19.

UroGen Pharma Ltd. (Nasdaq: URGN) today announced the U.S. Food and Drug Administration (FDA) granted expedited approval for Jelmyto™ (mitomycin) for pyelocalyceal solution, a first-in-class treatment indicated for adults with low-grade upper tract urothelial cancer (LG UTUC).

Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter and year ended December 31, 2019.

MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of the serological Point-of-Care (POC) testing solution with immediate result. Based on MedMira’s unique and patented Rapid Vertical Flow® (RVF) technology, the newly developed REVEALCOVID-19TM delivers immediate results without the need for any additional equipment such as a reader or a timer.

According to the latest news from Science and Technology Daily, two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration of China, making them the first batch in this category.

Maximizing production of critical medical products to support increased patient care levels Protecting employee health and safety through enhanced infection control procedures Hiring up to 2,000 new employees globally -- 800 to join Baxter’s U.S. operations

Endoscopic Submucosal Dissection (ESD) has witnessed slow adoption in Western countries in the past. This is due to the continued referral of patients for surgery or Endoscopic Mucosal Resection (EMR) procedures.

According to the latest report published by Persistence Market Research titled “Lithotripsy Devices Market: Global Industry Analysis 2013-2017 and Forecast 2018–2026,” the Lithotripsy Devices Market is anticipated to expand at a CAGR of 4.3% during the forecast period in terms of value.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to TransCon hGH ( lonapegsomatropin ), as a treatment for growth hormone deficiency (GHD). TransCon hGH is an investigational long-acting prodrug of somatropin (human gro